Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ceftobiprole in complicated skin and skin structure infections
NCT00210899Phase 3Completed
- Sponsor
- Basilea Pharmaceutica
- Start
- Sep 2005
- Primary completion
- Oct 2006
- Modality
- Reversible Covalent Inhibitors
01
Overview
A Phase 3 trial of ceftobiprole medocaril in Skin and Skin Structure Infection (SSSI), sponsored by Basilea Pharmaceutica. Started Sep 2005; status: completed.
02
Drugs
ceftobiprole medocaril
03
Conditions
Skin and Skin Structure Infection (SSSI)
Beyond the preview
Go deeper on NCT00210899.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00210899.